SCHEMBL1974253

SCHEMBL1974253

c1ccc2cc3cc4cc5c(-c6cccc7cc8ccc9cc%10cc%11ccccc%11cc%10cc9c8cc67)cccc5cc4cc3cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.52
HSD17B10 Q99714 9/20 0.52
HIF1A Q16665 4/20 0.52
CYP1B1 Q16678 1/20 0.52
HPGD P15428 4/20 0.48
CYP1A2 P05177 4/20 0.48
TSHR P16473 4/20 0.43
CASP1 P29466 3/20 0.43
MAPK1 P28482 3/20 0.43
CASP7 P55210 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP3A4 P08684 2/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
HBB P68871 1/20 0.43
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
ERBB2 P04626 1/20 0.42
FYN P06241 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213062 1.00 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL11779555 0.94 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL27506937 0.93 ALDH1A1 (0.48) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL29538643 0.93 ALDH1A1 (0.48) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL29354014 0.91 ALDH1A1 (0.50) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL2871930 0.91 ALDH1A1 (0.50) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL311801 0.89 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL28305060 0.89 ALDH1A1 (0.42) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL28412629 0.88 ALDH1A1 (0.56) ALDH1A1HSD17B10HIF1ACYP1B1HPGD
SCHEMBL537002 0.88 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212934-B1 Formation of a thin film of molecular organic semiconductor material CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS ETABLISSEMENT PUBLIC A CARACTERE SCIENTIFIQUE ET T (FR) 2019-09-04 EP disclosed
US-8758508-B2 Formation of a thin film of molecular organic semiconductor material CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2014-06-24 US disclosed
US-8492192-B2 Composition for forming an organic semiconducting device CREATOR TECHNOLOGY B.V. (NL) 2013-07-23 US disclosed
US-20120273734-A1 COMPOSITION FOR FORMING AN ORGANIC SEMICONDUCTING DEVICE CREATOR TECHNOLOGY B.V. (NL) 2012-11-01 US disclosed
US-8241946-B2 Method of forming an organic semiconducting device by a melt technique CREATOR TECHNOLOGY B.V. (NL) 2012-08-14 US disclosed
EP-1743390-B1 METHOD OF FORMING AN ORGANIC SEMICONDUCTING DEVICE BY A MELT TECHNIQUE CREATOR TECHNOLOGY BV (NL) 2011-07-27 EP disclosed
US-20110139063-A1 FORMATION OF A THIN FILM OF MOLECULAR ORGANIC SEMICONDUCTOR MATERIAL COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2011-06-16 US disclosed
EP-2212934-A1 FORMATION OF A THIN FILM OF MOLECULAR ORGANIC SEMICONDUCTOR MATERIAL Centre National de la Recherche Scientifique (CNRS) Etablissement Public à Caractère Scientifique et Technologique (FR) 2010-08-04 EP disclosed
WO-2009053473-A1 FORMATION OF A THIN FILM OF MOLECULAR ORGANIC SEMICONDUCTOR MATERIAL CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2009-04-30 WO disclosed
US-20080254568-A1 Composition and Method of Forming a Device KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) 2008-10-16 US disclosed
CN-1947276-A Method for producing organic semiconductor devices by means of fusion technology KONINKL PHILIPS ELECTRONICS NV (NL) 2007-04-11 CN disclosed
EP-1743390-A1 METHOD OF FORMING AN ORGANIC SEMICONDUCTING DEVICE BY A MELT TECHNIQUE Koninklijke Philips Electronics N.V. (NL) 2007-01-17 EP disclosed
WO-2005104265-A1 METHOD OF FORMING AN ORGANIC SEMICONDUCTING DEVICE BY A MELT TECHNIQUE KONINKLIJKE PHILIPS ELECTRONICS, N.V. (US) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120273734-A1 COMPOSITION FOR FORMING AN ORGANIC SEMICONDUCTING DEVICE DACH1, DSG1, DSP ALDH1A1 1580/4885HSD17B10 1143/4885HIF1A 4210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.